HER2: Clinical Trials

2 trials for HER2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2

Follow HER2: new trials by email Literature Review of HER2 trials Research Report on HER2

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression
RC48, Tislelizumab - Non-Muscle Invasive Bladder Cancer, HER2
Phase 2UnknownRenJi Hospital202023-08-052023-08-31
Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System
chemotherapy in combination with trastuzumab for arm1, chemotherapy in combination with trastuzumab for arm2, chemotherapy in combination with trastuzumab for arm3 - Targeted Therapy, HER2
Phase 2UnknownShen Lin1002017-07-012019-07-19

Narrower conditions

Biliary Tract Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Esophageal Squamous Cell Carcinoma (1)  ·  Non-Muscle Invasive Bladder Neoplasms (1)

Broader conditions

Carcinoma (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Biliary Tract Diseases (1)  ·  Carcinoma, Squamous Cell (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Esophageal Diseases (1)  ·  Esophageal Neoplasms (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gastrointestinal Diseases (1)

Interventions

26S proteasome non-ATPase regulatory subunit 13 (1)  ·  Drug Therapy (1)  ·  JPT1 protein, human (1)  ·  Trastuzumab (1)  ·  disitamab vedotin (1)  ·  tislelizumab (1)

Sponsors

RenJi Hospital (1)  ·  Shen Lin (1)

Countries

China (2)

Top investigators

Lin Shen, Master (1)

Results publications

PMID 36550683